Multidisciplinary Management Strategies for Long COVID: A Narrative Review.

a multidisciplinary approach for long covid a narrative review for long covid management management strategies for long covid post-acute sequelae sars-cov-2 infection severe acute respiratory syndrome coronavirus 2

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
May 2024
Historique:
accepted: 02 04 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of infections to date and has led to a worldwide pandemic. Most patients had a complete recovery from the acute infection, however, a large number of the affected individuals experienced symptoms that persisted more than 3 months after diagnosis. These symptoms most commonly include fatigue, memory difficulties, brain fog, dyspnea, cough, and other less common ones such as headache, chest pain, paresthesias, mood changes, muscle pain, and weakness, skin rashes, and cardiac, endocrine, renal and hepatic manifestations. The treatment of this syndrome remains challenging. A multidisciplinary approach to address combinations of symptoms affecting multiple organ systems has been widely adopted. This narrative review aims to bridge the gap surrounding the broad treatment approaches by providing an overview of multidisciplinary management strategies for the most common long COVID conditions.

Identifiants

pubmed: 38826995
doi: 10.7759/cureus.59478
pmc: PMC11142761
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e59478

Informations de copyright

Copyright © 2024, Prusinski et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Christian Prusinski (C)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.

Dan Yan (D)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.

Johana Klasova (J)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.

Kimberly H McVeigh (KH)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.

Sadia Z Shah (SZ)

Department of Transplantation, Mayo Clinic, Jacksonville, USA.

Olga P Fermo (OP)

Department of Neurology, Mayo Clinic, Jacksonville, USA.

Eva Kubrova (E)

Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA.

Ellen M Farr (EM)

Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA.

Linus C Williams (LC)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.
Department of Internal Medicine, Lahey Hospital & Medical Center, Burlington, USA.

Gerardo Gerardo-Manrique (G)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA.

Thomas F Bergquist (TF)

Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA.
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, USA.

Si M Pham (SM)

Department of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, USA.

Erica Engelberg-Cook (E)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.

Joshua M Hare (JM)

Department of Medicine, Cardiovascular Division and the Interdisciplinary Stem Cell Institute, Miami, USA.

Keith L March (KL)

Division of Cardiovascular Medicine, Center for Regenerative Medicine, University of Florida, Gainesville, USA.

Arnold I Caplan (AI)

Department of Biology, Case Western Reserve University School of Medicine, Cleveland, USA.

Wenchun Qu (W)

Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.
Center for Regenerative Biotherapeutics, Mayo Clinic, Jacksonville, USA.

Classifications MeSH